Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

A novel immunoassay for the quantization of CYFRA 21-1 in human serum.

He A, Liu TC, Dong ZN, Ren ZQ, Hou JY, Li M, Wu YS.

J Clin Lab Anal. 2013 Jul;27(4):277-83. doi: 10.1002/jcla.21597.

PMID:
23852784
3.

Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.

Patel JL, Erickson JA, Roberts WL, Grenache DG.

Clin Biochem. 2010 Dec;43(18):1449-52. doi: 10.1016/j.clinbiochem.2010.09.014. Epub 2010 Sep 27.

PMID:
20875814
4.

Assessment of serum CYFRA 21-1 in lung cancer.

Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S.

Cancer. 1996 Apr 1;77(7):1274-7.

5.

Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.

Song WA, Liu X, Tian XD, Wang W, Liang CY, Zhang T, Guo JT, Peng YH, Zhou NK.

Chin Med J (Engl). 2011 Oct;124(20):3244-8.

PMID:
22088515
6.
7.
8.

Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

Okamura K, Takayama K, Izumi M, Harada T, Furuyama K, Nakanishi Y.

Lung Cancer. 2013 Apr;80(1):45-9. doi: 10.1016/j.lungcan.2013.01.002. Epub 2013 Jan 23.

PMID:
23352032
9.

[Development of an amplified luminescent proximity homogeneous immunoassay kit for detecting human hepatitis B virus e antibody].

Ma Q, He A, Dong ZN, Liu TC, Zou LP, Lin GF, Li M, Wu YS.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):810-2. Chinese.

10.

CYFRA 21-1 as a tool for distant metastasis detection in lung cancer.

Cabrera-Alarcon JL, Carrillo-Vico A, Santotoribio JD, Leon-Justel A, Sanchez-Gil R, Gonzalez-Castro A, Guerrero JM.

Clin Lab. 2011;57(11-12):1011-4.

PMID:
22239035
11.

Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.

Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E.

Eur J Clin Chem Clin Biochem. 1994 Mar;32(3):189-99.

PMID:
7518259
12.

Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.

Park Y, Kim Y, Lee JH, Lee EY, Kim HS.

Arch Pathol Lab Med. 2011 Dec;135(12):1570-5. doi: 10.5858/arpa.2010-0717-OA.

PMID:
22129186
13.
14.

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

Yu JP, Xu XG, Ma RJ, Qin SN, Wang CR, Wang XB, Li M, Li MS, Ma Q, Xu WW.

J Clin Lab Anal. 2015 Mar;29(2):85-93. doi: 10.1002/jcla.21733. Epub 2014 Mar 28.

PMID:
24687454
15.

Biomarkers in the lung cancer diagnosis: a clinical perspective.

Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M.

Neoplasma. 2012;59(5):500-7. doi: 10.4149/neo_2012_064.

PMID:
22668014
16.

Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA).

Zhao H, Lin G, Liu T, Liang J, Ren Z, Liang R, Chen B, Huang W, Wu Y.

J Immunol Methods. 2016 Oct;437:64-9. doi: 10.1016/j.jim.2016.08.006. Epub 2016 Aug 24.

PMID:
27568283
17.

Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.

Lai RS, Chen CC, Lee PC, Lu JY.

Jpn J Clin Oncol. 1999 Sep;29(9):421-4.

PMID:
10563194
18.

The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.

Wang P, Piao Y, Zhang X, Li W, Hao X.

Cancer Biomark. 2013;13(2):123-30. doi: 10.3233/CBM-130338.

PMID:
23838141
19.

CYFRA 21-1. A new marker in lung cancer.

Stieber P, Hasholzner U, Bodenmüller H, Nagel D, Sunder-Plassmann L, Dienemann H, Meier W, Fateh-Moghadam A.

Cancer. 1993 Aug 1;72(3):707-13.

20.

Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer.

Hur J, Lee HJ, Nam JE, Kim YJ, Hong YJ, Kim HY, Kim SK, Chang J, Kim JH, Chung KY, Lee HS, Choi BW.

BMC Cancer. 2012 Sep 7;12:392. doi: 10.1186/1471-2407-12-392.

Supplemental Content

Support Center